AssetIndicationPre-ClinicalIND-Enabling StudiesPhase 1Phase 2Phase 3
OK-101
Dry Eye
started phase 2 in Q2/2023

Uveitis

Allergic Conjunctivitis

Ocular Pain

OK-201
Discovery Program

DrugIndicationStage
OK-101
Dry Eye Phase 1*
Uveitis Pre-Clinical
Allergic Conjunctivitis Pre-Clinical
Ocular Pain Pre-Clinical
OK-201
Discovery Program
*started phase 2 in Q2/2023

OK-101 Development Timeline